Requirement of Interleukin‐17A for Systemic Anti– Candida albicans Host Defense in Mice
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
T cells are required for normal host defense against fungal infection, and individuals with T cell-deficiency syndromes are highly susceptible to fungal pathogens. Interleukin (IL)-17A is a proinflammatory cytokine that interconnects myeloid and lymphoid host defense. The role of murine (m) IL-17A/mIL-17A receptor (R) interactions was evaluated in a murine model of systemic candidiasis. In response to systemic challenge with Candida albicans, expression of mIL-17A was induced, and IL-17AR knockout (IL-17AR(-/-)) mice had dose-dependent, substantially reduced survival. Fungal burden in the kidneys of IL-17AR(-/-) mice was dramatically increased (25-fold at 96 h). In IL-17AR(-/-) mice, both mobilization of peripheral neutrophils and their influx to infected organs were significantly impaired and delayed. In vivo expression of mIL-17A protected normal mice from a lethal dose of C. albicans (100% at day 7 and 65% at day 42). The data suggest that the mIL-17A/mIL-17AR system is required for normal fungal host defense in vivo. IL-17A could have potential as a therapeutic cytokine for systemic C. albicans infections in immunocompromised patients with cancer or advanced acquired immunodeficiency syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Confirming previous reports, IL-17RA-/- mice demonstrated significantly increased kidney fungal burden in comparison to WT following infection with C. albicans (CAF2-1 or SC5314) (Fig 1A) [14,16,33].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
In the citing paper
“IL-17RA-/-, IL-17RC-/-, RORγt-/- and IL-17A-/- mice are all susceptible to systemic C. albicans infection [14–17].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
In the citing paper
“During candidiasis, IL-17 is rapidly upregulated in the kidney, but its function in that organ is unknown [14].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
In the citing paper
“IL-17 is a key mediator of defense against candidiasis.”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
In the citing paper
“In recent years, considerable data have implicated IL-17 in immunity against disseminated candidiasis [14–16].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Ye, P., Rodriguez, F. H., Kanaly, S., Stocking, K. L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.519 · Cited by 1,521
Self-citationTrends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997
McNeil, M. M., Nash, S. L., Hajjeh, R. A., Phelan, M. A., Conn, L. A., Plikaytis, B. D., & Warnock, D. W. (2001) · Clinical Infectious Diseases · doi:10.1086/322606 · Cited by 657 · cited 1×
“suppressive cancer chemotherapy, especially if this treatment is followed by prolonged periods of neutropenia, such as seen in bone marrow transplantation [1, 2].”
BackgroundIL-17: prototype member of an emerging cytokine family
Aggarwal, S., & Gurney, A. L. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.1.1 · Cited by 597 · cited 1×
“tem, because of its unique effects [14].”
Interleukin-17 and Lung Host Defense against Klebsiella pneumoniae Infection
Ye, P., Garvey, P. B., Zhang, P., Nelson, S., Bagby, G., Summer, W. R., Schwarzenberger, P., Shellito, J. E., & Kolls, J. K. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.3.4424 · Cited by 461 · cited 2×
“Although statistically significant, this finding was less pronounced than that observed in our previous studies of gram-negative bacteria challenge, in which IL17AR / mice failed entirely to mount a peripheral neutrophil response [8, 9].”
ResultSelf-citationSchwarzenberger, P., La Russa, V., Miller, A., Ye, P., Huang, W., Zieske, A., Nelson, S., Bagby, G. J., Stoltz, D., Mynatt, R. L., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6383 · Cited by 325 · cited 5×
“neutrophils and their precursors [7, 9] (data not shown).”
BackgroundMethodInfluentialSelf-citationAntibody response that protects against disseminated candidiasis
Han, Y., & Cutler, J. E. (1995) · Infection and Immunity · doi:10.1128/iai.63.7.2714-2719.1995 · Cited by 308 · cited 1×
“teractions between T cells and phagocytes and have reported that this phenomenon directly augments fungicidal properties [21-24].”
BackgroundCAUSES OF DEATH IN ADULTS WITH ACUTE LEUKEMIA
CHANG, H.-Y., RODRIGUEZ, V., NARBONI, G., BODEY, G. P., LUNA, M. A., & FREIREICH, E. J. (1976) · Medicine · doi:10.1097/00005792-197605000-00005 · Cited by 301 · cited 2×
“individuals [1, 5].”
Schwarzenberger, P., Huang, W., Ye, P., Oliver, P., Manuel, M., Zhang, Z., Bagby, G., Nelson, S., & Kolls, J. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4783 · Cited by 277 · cited 1×
“mIL-17A was found to exert significant effects on neutrophils and its precursors, not directly, but, to a large extent, via the induction and release of secondary or downstream cytokines from stromal cells [7, 15].”
BackgroundSelf-citationInfectious Complications of Chronic Lymphocytic Leukemia
WADHWA, P., & MORRISON, V (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.12.013 · Cited by 276 · cited 1×
“related to clinical outcomes [5, 6].”
Bacteremia and Fungemia in Patients with the Acquired Immunodeficiency Syndrome
WHIMBEY, E., GOLD, J. W. M., POLSKY, B., DRYJANSKI, J., HAWKINS, C., BLEVINS, A., BRANNON, P., KIEHN, T. E., BROWN, A. E., & ARMSTRONG, D. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-4-511 · Cited by 239 · cited 3×
“The data are encouraging for pursuing further development of mIL-17A in fungal infections, which could benefit immunocompromised individuals, especially patients with cancer or AIDS.”
BackgroundLayton, J., Hockman, H., Sheridan, W., & Morstyn, G. (1989) · Blood · doi:10.1182/blood.v74.4.1303.1303 · Cited by 227 · cited 9×
“Moreover, mIL-17A was found to function, at least in part, via release of G-CSF from stromal cells, and administration of G-CSF has been reported to protect mice from lethal C. albicans challenges in neutropenic and nonneutropenic mice [15, 28, 29].”
BackgroundInfluentialBodey, G. P., Mardani, M., Hanna, H. A., Boktour, M., Abbas, J., Girgawy, E., Hachem, R. Y., Kontoyiannis, D. P., & Raad, I. I. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01130-5 · Cited by 209 · cited 1×
“such as seen in bone marrow transplantation [1, 2].”
BackgroundHübel, K., Dale, D. C., & Liles, W. C. (2002) · The Journal of Infectious Diseases · doi:10.1086/340221 · Cited by 150 · cited 1×
“Several of these mIL-17A–induced downstream cytokines, such as G-CSF and IL-8, have direct neutrophil-activating properties [19, 20].”
Background“Emergency” granulopoiesis in G-CSF–deficient mice in response to Candida albicans infection
Basu, S., Hodgson, G., Zhang, H.-H., Katz, M., Quilici, C., & Dunn, A. R. (2000) · Blood · doi:10.1182/blood.v95.12.3725 · Cited by 144
Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients
Laverdiere, M. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.6.1001 · Cited by 83
Mencacci, A., Perruccio, K., Bacci, A., Cenci, E., Benedetti, R., Martelli, M. F., Bistoni, F., Coffman, R., Velardi, A., & Romani, L. (2001) · Blood · doi:10.1182/blood.v97.5.1483 · Cited by 78 · cited 2×
“albicans sepsis [10–13].”
BackgroundMartino, P., Girmenia, C., Micozzi, A., Bernardis, F. D., Boccanera, M., & Cassone, A. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02111339 · Cited by 73 · cited 1×
“incidence of systemic candidiasis [3, 4].”
Miyake, T., Takeya, K., Nomoto, K., & Muraoka, S. (1977) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1977.tb00339.x · Cited by 57 · cited 1×
“teractions between T cells and phagocytes and have reported that this phenomenon directly augments fungicidal properties [21-24].”
BackgroundSherry, B. A., & Cerami, A. (1991) · Current Opinion in Immunology · doi:10.1016/0952-7915(91)90077-e · Cited by 54 · cited 1×
“Several of these mIL-17A–induced downstream cytokines, such as G-CSF and IL-8, have direct neutrophil-activating properties [19, 20].”
BackgroundKullberg, B. J., Netea, M. G., Curfs, J. H. A. J., Keuter, M., Meis, J. F. G. M., & van der Meer, J. W. M. (1998) · The Journal of Infectious Diseases · doi:10.1086/513812 · Cited by 54 · cited 1×
“albicans challenges in neutropenic and nonneutropenic mice [15, 28, 29].”
BackgroundAcquired Immunity to Systemic Candidiasis in Immunodeficient Mice
Cantorna, M. T., & Balish, E. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/164.5.936 · Cited by 51 · cited 1×
“teractions between T cells and phagocytes and have reported that this phenomenon directly augments fungicidal properties [21-24].”
BackgroundWilliams, F. M. K., Kus, M., Tanda, K., & Williams, T. J. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14861.x · Cited by 48 · cited 2×
“Expression of MPO has been commonly used for quantification of neutrophils in tissue [17].”
MethodIncreased Resistance to Systemic Candidiasis in Athymic or Interleukin‐10–Depleted Mice
Tavares, D., Ferreira, P., & Arala-Chaves, M. P. (2000) · The Journal of Infectious Diseases · doi:10.1086/315674 · Cited by 35 · cited 2×
“albicans sepsis [10–13].”
BackgroundFungemia in HIV-Infected Patients: A 12-Year Study in a Tertiary Care Hospital
Garbino, J., Kolarova, L., Lew, D., Hirschel, B. J., & Rohner, P. (2001) · AIDS Patient Care and STDs · doi:10.1089/108729101316914403 · Cited by 33 · cited 3×
“The data are encouraging for pursuing further development of mIL-17A in fungal infections, which could benefit immunocompromised individuals, especially patients with cancer or AIDS.”
BackgroundAshman, R. B., Fulurija, A., & Papadimitriou, J. M. (1999) · Microbiology · doi:10.1099/13500872-145-7-1631 · Cited by 29 · cited 1×
“However, other investigators have suggested that activation of T cells during fungal tissue inflammation can lead to accelerated tissue injury, which could result in increased mortality [27].”
BackgroundHamood, M., Bluche, P. F., Vroey, C. D., Corazza, F., Buján, W., & Fondu, P. (1994) · Mycoses · doi:10.1111/j.1439-0507.1994.tb00783.x · Cited by 27 · cited 1×
“albicans challenges in neutropenic and nonneutropenic mice [15, 28, 29].”
BackgroundDifferential effects of CD4+ and CD8+ cells in acute, systemic murine candidosis
Coker, L. A., MERCADAL, C. M., Rouse, B. T., & Moore, R. N. (1992) · Journal of Leukocyte Biology · doi:10.1002/jlb.51.3.305 · Cited by 25 · cited 2×
“albicans sepsis [10–13].”
BackgroundSchwarzenberger, P. O., Huang, W., Oliver, P., Theodossiou, C., Osidipe, T., & Kolls, J. K. (2001) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200102000-00004 · Cited by 18 · cited 1×
“Construction, generation, expansion, and quality control of adenovirus-expressing mIL-7A (Ad-mIL-17A) and the control virus (AdEGFP or AdCMVLuc) have been described elsewhere [7, 16].”
BackgroundSelf-citationFulurija, A., Ashman, R. B., & Papadimitriou, J. M. (1997) · Medical Mycology · doi:10.1080/02681219780001141 · Cited by 15 · cited 2×
“albicans sepsis [10–13].”
BackgroundActivated CD3+ T cells are involved in elimination of Candida albicans from the livers of mice
Kretschmar, M., Jung, C. S., Fontagnier, E., Quade, B., Nichterlein, T., & Hof, H. (1997) · Mycoses · doi:10.1111/j.1439-0507.1997.tb00169.x · Cited by 8 · cited 1×
“teractions between T cells and phagocytes and have reported that this phenomenon directly augments fungicidal properties [21-24].”
Background
Cited by
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
“Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice.”
BackgroundInfluentialRegulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A., & Hymowitz, S. G. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101312 · Cited by 1,925
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., & Napolitani, G. (2007) · Nature Immunology · doi:10.1038/ni1467 · Cited by 1,828
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793
The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
Ouyang, W., Kolls, J. K., & Zheng, Y. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.004 · Cited by 1,700
“IL-17RA-deficient mice are also susceptible to Toxoplasmosis gondii (Kelly et al., 2005) and Candida albicans infection (Huang et al., 2004).”
Metadata
- Authors
- Huang, W., Na, L., Fidel, P. L., & Schwarzenberger, P.
- Affiliations
- Louisiana State University Health Sciences Center New Orleans (US)
- Corresponding author
- Huang, Weitao
- ORCID
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08
- Volume
- 190
- Issue
- 3
- Pages
- 624-631
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2112133235
- Cited by
- 859
- References
- 30
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 25 · 2023: 21 · 2022: 20 · 2021: 23 · 2020: 19 · 2019: 23 · 2018: 28 · 2017: 35 · 2016: 41 · 2015: 53 · 2014: 48 · 2013: 52 · 2012: 74
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA081125)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17A, IL-17 receptor, Candida albicans, systemic candidiasis, neutrophil recruitment, T cell-dependent immunity, immunocompromised patients
- MeSH terms
- Animals, Candida albicans, Candidiasis, Disease Models, Animal, Humans, Kidney, Mice, Inbred C57BL, Recombinant Proteins, Receptors, Interleukin, Mice, Knockout, Interleukin-17, Mice, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.